Hypertrophic osteoarthropathy, primary or idiopathic
Hypertrophic Osteoarthropathy, Primary or Idiopathic (PHO) is a rare medical condition characterized by the clubbing of fingers and toes, periostitis of the long bones, and arthritis. This condition is considered idiopathic because its cause is unknown, distinguishing it from secondary hypertrophic osteoarthropathy, which is associated with other diseases, particularly pulmonary conditions.
Etiology and Pathogenesis[edit | edit source]
The exact cause of Primary Hypertrophic Osteoarthropathy (PHO) remains unknown. However, it is believed to involve genetic factors, as cases have been reported in familial clusters. The pathogenesis is thought to involve vascular endothelial growth factor (VEGF) and other pro-inflammatory cytokines, which lead to vascular proliferation and subsequent changes in the bones and skin.
Clinical Features[edit | edit source]
Patients with PHO typically present with clubbing of the fingers and toes, a condition where the ends of the fingers and toes swell and form a bulbous appearance. Other symptoms include joint pain, swelling (arthritis), and periostitis, which is an inflammation of the periosteum, a layer of connective tissue surrounding the bone. This inflammation can lead to painful, tender limbs and is often detected on radiographic imaging.
Diagnosis[edit | edit source]
The diagnosis of PHO is primarily clinical, based on the characteristic symptoms and signs. Radiographs or other imaging techniques such as bone scans can reveal periostitis. In some cases, blood tests may be conducted to rule out other conditions that can cause similar symptoms, including secondary causes of hypertrophic osteoarthropathy.
Treatment[edit | edit source]
Treatment of PHO is symptomatic and may include nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. In severe cases, more potent medications such as corticosteroids or immunosuppressive drugs may be considered. Physical therapy may also be beneficial in managing symptoms. Since the underlying cause of PHO is not well understood, there is no definitive cure, and treatment focuses on managing symptoms and improving quality of life.
Prognosis[edit | edit source]
The prognosis for individuals with PHO varies. While the condition can cause significant discomfort and impact quality of life, it is not typically life-threatening. Symptom management and regular medical care can help patients lead relatively normal lives.
Epidemiology[edit | edit source]
PHO is a rare condition, though the exact prevalence is unknown due to its rarity and possible underdiagnosis. It can affect individuals of any age but is most commonly diagnosed in adolescents and young adults. There is no known gender or racial predilection.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD